Member Info for Lp160606

They'll certainly know more than us, that is for sure.

I agree, GG.

The NIHR would not fast track any old medical trial. I would expect their due diligence to include disclosure of initial data of Southampton in order to sponsor & expand.

I do not know this as fact, but it would be bizarre for them not to talk through their thesis and how initial findings have supported this.

Jack. The CMO is one of the leads of the NIHR. The Agency that fast tracked us. He will know exactly who we are, and the progress we are making.

What he tells the public is a different story.

Press is pointless if we fail. Not sure why you're all so bothered by it if i'm honest unless you're looking for an exit pre results.

5-10x more effective based on medical journals.

Exactly Miggy. We're on the same page there.

I'm excited for the coming weeks. I feel a little bit shafted by the walk down but such is life. I'm confident of success. We have the ability to scale at speed and genuinely release the pressure on the NHS (should it work as we think it will). Would love to see it as a proactive offering but I'm getting ahead of myself a little.

Our trial will have concluded by the time the WHO have the data to intervene with our outcomes.

Entering our 4th week. We will have initial data now. Another 2-3 weeks we will have conclusive results (I think)

I just see the involvement of interferon on a global trail as yet another proof point of the value we have here. In a solution administered direct to the lungs. They are utilising what we consider the b team. As there are side effects with infection and it is diluted prior to reaching the area it needs to get to.

They will be using the injected method. Not nebulised.

We don't own the right the drug. But the delivery method.

Johnny mate. Fantastic find.

Doesn't matter if it isn't us. It is our bloody drug. Another tick box.

To see 0 gains off the back of that is ridiculous.

I've read the strategic doc. No increase in requirement in the states as of yet is a direct quote.

Kiwi, they have formalised dates for q1 trading update? Or do you mean Q2?

Was this not it?

We are not currently included in the recovery trial.

Interesting.

He is a specialist in..
Immunopathogenesis of airway disease namely asthma, chronic obstructive pulmonary disease (COPD) and chronic cough;
Current projects include understanding the interactions between mast cells and airway smooth muscle cells in the development of the asthmatic phenotype, airway smooth muscle migration and remodelling in asthma and COPD.

I would very much like an update on Trial sites. Sneaking the study being made into an urgent public health study was in hindsight a little disappointing, it warranted its on RNS in my opinion.

That being said, prospective is required.

It is going well, we know this to be fact as it has not been stopped, has been widened to more sites & made an urgent study.
There is copious amount of evidence suggesting Interferon is effective in Covid-19 patients. - Medical journals out of China.
In varying forms in is being used in the most severe cases & as a preventative measure.
French/Canadian/Iranian/India are pushing for trials and its use.
The company are under no requirement to constantly update the market. (the Ceo said this is no share for day traders)

We are at most 2 weeks away. on success we are a Billion £ company overnight.

Indeed. Shocked at the slight sell off there.

Got the Analyst briefing at 10:30, followed by the 1630 session.

A news rich few sessions.

Going off this it is going to be nothing but goo news for LID

Very solid last 3 months. Now in profit is great. Makes them an even more attractive target for takeover.

Would love to know more around the NHS engagement and what their disti in the states is up too.

Surely very busy.

aha fair point with the German TV piece. Very vague and now disappeared

But in all honesty, education is key here. I lost a fair amount in my first few positions. No expert myself but i found educating yourself on general financing & how markets work is key.

Do not rely on people here, this is a decent board but generally everyone has their own agenda. Google is your best friend.

NIce find, Jay! Top of the list as well.

Great to see

Good sign. **** munchers are desperate for it. Been walking this down for days now.

In the end 20% either side of current SP is irrelevant as they can't hold it back on results. However, Everything of any size has been delayed on this stock. They do not want constant rises, on the surface it is in their interests to make this look a dog. Of course sellers from Placing in also but manipulation is rife.

Roll on next week.

I'm expecting a very solid set of sales figures tomorrow.

As well as some insight on NHS involvement & US engagements. I would like to very much see an update on US penetration that was given core focus in Febs presentation.

Fingers crossed & good luck all.

There were buys on the £1.

Poor buggers.

JCEP, could you make this into a separate topic? Fantastic insight and very appreciated. I think it is of serious value and need to be seen on here.

Thanks again for sharing.